$0.5800
-0.0324-5.29%
Last update: Oct 16, 6:53 PM
$0.5984
-0.014-2.29%
Lakewood-Amedex Biotherapeutics Inc (LABT) Stock Price, Quote, News & History
LABTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Lakewood-Amedex (NASDAQ:LABT) through any online brokerage.
Other companies in Lakewood-Amedex’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Lakewood-Amedex to provide a consensus price target.
The stock price for Lakewood-Amedex (NASDAQ: LABT) is $0.5984 last updated October 16, 2026 at 6:53 PM EDT.
There are no upcoming dividends for Lakewood-Amedex.
Lakewood-Amedex does not have any upcoming earnings scheduled.
There is no upcoming split for Lakewood-Amedex.
Lakewood-Amedex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by...
